Home » Topics » BioWorld Science

BioWorld Science
RSS

E-7011, a neutralizing antibody targeting Notch4 to inhibit tumor growth

April 12, 2022

New small molecules synergize with ciprofloxacin against S. tiphy biofilms in the gallbladder

April 12, 2022

TLR9 inhibitor-loaded nanoparticles protect against radiation-induced BBB disruption

April 12, 2022

Targeting 5-HT1AR as novel therapeutic strategy for Fragile X syndrome

April 12, 2022

IMP-2 validated as cancer target, small-molecule inhibitors identified

April 12, 2022

Inhibition of kininase I prevents angiotensin II-induced hypertension

April 12, 2022

BCAT deletion from T cells may offer advantage to lymphoma immunotherapy

April 12, 2022

Phytos identifies new PD-L1 inhibitors

April 12, 2022

Zhejiang Hisun Pharmaceutical, Hisun Accuray Therapeutics patent anticoagulants

April 12, 2022

New N-myristoyltransferase inhibitors presented by MyricX Pharma, Imperial Innovations Group

April 12, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...